The company has utilized Rs 4,860.45 million of the Rs 6,300 million initially earmarked for capital expenditure and Rs 1,149.61 million of the Rs 1,158.34 million designated for general corporate purposes, leaving a remaining balance of Rs 1,469 million as of July 2026. According to a report by Crisil Ratings Limited, the delay in full utilization, originally planned for Fiscal 2026, is attributed to project timelines, market conditions, business requirements, and the availability of existing funding arrangements with IREDA. The company intends to deploy the remaining funds in Fiscal 2027, with portions currently held in a Public Offer Account, PREPL TRA and other accounts. The report notes that the reliance on IREDA funding influenced the timing of fund deployment and includes standard disclaimers regarding accuracy, liability, and investment advice.